Marcus Bantscheff
Marcus Bantscheff
Cellzome, a GSK company
Verified email at
Cited by
Cited by
Quantitative mass spectrometry in proteomics: a critical review
M Bantscheff, M Schirle, G Sweetman, J Rick, B Kuster
Analytical and bioanalytical chemistry 389, 1017-1031, 2007
Mass-spectrometry-based draft of the human proteome
M Wilhelm, J Schlegl, H Hahne, AM Gholami, M Lieberenz, MM Savitski, ...
Nature 509 (7502), 582-587, 2014
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
MA Dawson, RK Prinjha, A Dittmann, G Giotopoulos, M Bantscheff, ...
Nature 478 (7370), 529-533, 2011
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M Bantscheff, D Eberhard, Y Abraham, S Bastuck, M Boesche, S Hobson, ...
Nature biotechnology 25 (9), 1035-1044, 2007
Catalytic in vivo protein knockdown by small-molecule PROTACs
DP Bondeson, A Mares, IED Smith, E Ko, S Campos, AH Miah, ...
Nature chemical biology 11 (8), 611-617, 2015
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
M Bantscheff, S Lemeer, MM Savitski, B Kuster
Analytical and bioanalytical chemistry 404, 939-965, 2012
Tracking cancer drugs in living cells by thermal profiling of the proteome
MM Savitski, FBM Reinhard, H Franken, T Werner, MF Savitski, ...
Science 346 (6205), 1255784, 2014
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
L Kruidenier, C Chung, Z Cheng, J Liddle, KH Che, G Joberty, ...
Nature 488 (7411), 404-408, 2012
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
M Bantscheff, C Hopf, MM Savitski, A Dittmann, P Grandi, AM Michon, ...
Nature biotechnology 29 (3), 255-265, 2011
Design of amidobenzimidazole STING receptor agonists with systemic activity
JM Ramanjulu, GS Pesiridis, J Yang, N Concha, R Singhaus, SY Zhang, ...
Nature 564 (7736), 439-443, 2018
Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry
H Franken, T Mathieson, D Childs, GMA Sweetman, T Werner, I Tögel, ...
Nature protocols 10 (10), 1567-1593, 2015
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
J Chapuis, F Hansmannel, M Gistelinck, A Mounier, ...
Molecular psychiatry 18 (11), 1225-1234, 2013
A scalable approach for protein false discovery rate estimation in large proteomic data sets [s]
MM Savitski, M Wilhelm, H Hahne, B Kuster, M Bantscheff
Molecular & Cellular Proteomics 14 (9), 2394-2404, 2015
Mass-spectrometry-based draft of the Arabidopsis proteome
J Mergner, M Frejno, M List, M Papacek, X Chen, A Chaudhary, ...
Nature 579 (7799), 409-414, 2020
Systematic analysis of protein turnover in primary cells
T Mathieson, H Franken, J Kosinski, N Kurzawa, N Zinn, G Sweetman, ...
Nature communications 9 (1), 689, 2018
Confident phosphorylation site localization using the Mascot Delta Score
MM Savitski, S Lemeer, M Boesche, M Lang, T Mathieson, M Bantscheff, ...
Molecular & cellular proteomics 10 (2), S1-S12, 2011
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
O Gilan, I Rioja, K Knezevic, MJ Bell, MM Yeung, NR Harker, EYN Lam, ...
Science 368 (6489), 387-394, 2020
Robust and sensitive iTRAQ quantification on an LTQ Orbitrap mass spectrometer
M Bantscheff, M Boesche, D Eberhard, T Matthieson, G Sweetman, ...
Molecular & Cellular Proteomics 7 (9), 1702-1713, 2008
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
FBM Reinhard, D Eberhard, T Werner, H Franken, D Childs, C Doce, ...
Nature methods 12 (12), 1129-1131, 2015
Measuring and managing ratio compression for accurate iTRAQ/TMT quantification
MM Savitski, T Mathieson, N Zinn, G Sweetman, C Doce, I Becher, ...
Journal of proteome research 12 (8), 3586-3598, 2013
The system can't perform the operation now. Try again later.
Articles 1–20